Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 91.1 CHF 2.94% Market Closed
Market Cap: 1.2B CHF

Medartis Holding AG
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medartis Holding AG
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
Gross Profit
CHf187m
CAGR 3-Years
8%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
Gross Profit
$5.4B
CAGR 3-Years
4%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
Gross Profit
CHf159.1m
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
Gross Profit
CHf292.1m
CAGR 3-Years
37%
CAGR 5-Years
26%
CAGR 10-Years
13%
IVF Hartmann Holding AG
SIX:VBSN
Gross Profit
CHf88.8m
CAGR 3-Years
6%
CAGR 5-Years
2%
CAGR 10-Years
1%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
1.1B CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
93.21 CHF
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Medartis Holding AG's Gross Profit?
Gross Profit
187m CHF

Based on the financial report for Jun 30, 2025, Medartis Holding AG's Gross Profit amounts to 187m CHF.

What is Medartis Holding AG's Gross Profit growth rate?
Gross Profit CAGR 5Y
12%

Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for Medartis Holding AG have been 8% over the past three years , 12% over the past five years .

Back to Top